Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins

被引:53
作者
Achdout, Hagit [1 ]
Manaster, Irit [1 ]
Mandelboim, Ofer [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel
关键词
D O I
10.1128/JVI.00870-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The killing by natural killer (NK) cells is regulated by inhibitory, costimulatory, and activating receptors. The inhibitory receptors recognize mainly major histocompatibility complex (MHC) class I molecules, while the activating NK receptors recognize stress-induced ligands and viral products. Thus, changes in the expression of the various inhibitory and activating ligands will determine whether target cells will be killed or protected. Here, we demonstrate that after influenza virus infection the binding of the two NK inhibitory receptors, KIR2DL1 and the LIR1, to the infected cells is specifically increased. The increased binding occurs shortly after the influenza virus infection, prior to the increased recognition of the infected cells by the NK activating receptor, NKp46. We also elucidate the mechanism responsible for this effect and demonstrate that, after influenza virus infection, MHC class I proteins redistribute on the cell surface and accumulate in the lipid raft microdomains. Such redistribution allows better recognition by the NK inhibitory receptors and consequently increases resistance to NK cell attack. In contrast, T-cell activity was not influenced by the redistribution of MHC class I proteins. Thus, we present here a novel mechanism, developed by the influenza virus, of inhibition of NK cell cytotoxicity, through the reorganization of MHC class I proteins on the cell surface.
引用
收藏
页码:8030 / 8037
页数:8
相关论文
共 56 条
  • [1] Enhanced recognition of human NK receptors after influenza virus infection
    Achdout, H
    Arnon, TI
    Markel, G
    Gonen-Gross, T
    Lieberman, N
    Gazit, R
    Joseph, A
    Kedar, E
    Mandelboim, O
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (02) : 915 - 923
  • [2] Tumor and viral recognition by natural killer cells receptors
    Arnon, Tal I.
    Markel, Gal
    Mandelboim, Ofer
    [J]. SEMINARS IN CANCER BIOLOGY, 2006, 16 (05) : 348 - 358
  • [3] The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46
    Arnon, TI
    Achdout, H
    Lieberman, N
    Gazit, R
    Gonen-Gross, T
    Katz, G
    Bar-Ilan, A
    Bloushtain, N
    Lev, M
    Joseph, A
    Kedar, E
    Porgador, A
    Mandelboim, O
    [J]. BLOOD, 2004, 103 (02) : 664 - 672
  • [4] Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO
  • [5] 2-A
  • [6] N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors
    Baba, E
    Erskine, R
    Boyson, JE
    Cohen, GB
    Davis, DM
    Malik, P
    Mandelboim, O
    Reyburn, HT
    Strominger, JL
    [J]. HUMAN IMMUNOLOGY, 2000, 61 (12) : 1202 - 1218
  • [7] Human natural killer cell receptors and co-receptors
    Biassoni, R
    Cantoni, C
    Pende, D
    Sivori, S
    Parolini, S
    Vitale, M
    Bottino, C
    Moretta, A
    [J]. IMMUNOLOGICAL REVIEWS, 2001, 181 : 203 - 214
  • [8] Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells
    Bottino, C
    Moretta, L
    Pende, D
    Vitale, M
    Moretta, A
    [J]. MOLECULAR IMMUNOLOGY, 2004, 41 (6-7) : 569 - 575
  • [9] Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
    Boyington, JC
    Motyka, SA
    Schuck, P
    Brooks, AG
    Sun, PD
    [J]. NATURE, 2000, 405 (6786) : 537 - 543
  • [10] NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
    Cantoni, C
    Bottino, C
    Vitale, M
    Pessino, A
    Augugliaro, R
    Malaspina, A
    Parolini, S
    Moretta, L
    Moretta, A
    Biassoni, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 787 - 795